Literature DB >> 23063407

Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

Birte Kalveram1, Olga Lihoradova, Sabarish V Indran, Nandadeva Lokugamage, Jennifer A Head, Tetsuro Ikegami.   

Abstract

Rift Valley fever virus (RVFV) encodes one major virulence factor, the NSs protein. NSs suppresses host general transcription, including interferon (IFN)-β mRNA synthesis, and promotes degradation of the dsRNA-dependent protein kinase (PKR). We generated a novel RVFV mutant (rMP12-NSsR173A) specifically lacking the function to promote PKR degradation. rMP12-NSsR173A infection induces early phosphorylation of eIF2α through PKR activation, while retaining the function to inhibit host general transcription including IFN-β gene inhibition. MP-12 NSs but not R173A NSs binds to wt PKR. R173A NSs formed filamentous structure in nucleus in a mosaic pattern, which was distinct from MP-12 NSs filament pattern. Due to early phosphorylation of eIF2α, rMP12-NSsR173A could not efficiently accumulate viral proteins. Our results suggest that NSs-mediated host general transcription suppression occurs independently of PKR degradation, while the PKR degradation is important to inhibit the phosphorylation of eIF2α in infected cells undergoing host general transcription suppression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063407      PMCID: PMC3534933          DOI: 10.1016/j.virol.2012.09.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR.

Authors:  S Li; A E Koromilas
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

2.  Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system.

Authors:  Naoto Ito; Mutsuyo Takayama-Ito; Kentaro Yamada; Junji Hosokawa; Makoto Sugiyama; Nobuyuki Minamoto
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

3.  Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 4.  Endoplasmic reticulum stress in health and disease.

Authors:  Lihong Zhao; Susan L Ackerman
Journal:  Curr Opin Cell Biol       Date:  2006-06-16       Impact factor: 8.382

5.  Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein.

Authors:  F Z Yadani; A Kohl; C Préhaud; A Billecocq; M Bouloy
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Authors:  Agnès Billecocq; Nicolas Gauliard; Nicolas Le May; Richard M Elliott; Ramon Flick; Michèle Bouloy
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

9.  Exploring RNA transcription and turnover in vivo by using click chemistry.

Authors:  Cindy Y Jao; Adrian Salic
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-07       Impact factor: 11.205

10.  A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.

Authors:  Nicolas Le May; Zeyni Mansuroglu; Psylvia Léger; Thibaut Josse; Guillaume Blot; Agnès Billecocq; Ramon Flick; Yves Jacob; Eliette Bonnefoy; Michèle Bouloy
Journal:  PLoS Pathog       Date:  2008-01       Impact factor: 6.823

View more
  20 in total

1.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

Review 2.  The Emergence of Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Jesus A Silvas; Patricia V Aguilar
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

3.  Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.

Authors:  Kaori Terasaki; Shinji Makino
Journal:  J Innate Immun       Date:  2015-02-27       Impact factor: 7.349

4.  Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.

Authors:  Kimberly K Roberts; Terence E Hill; Melissa N Davis; Michael R Holbrook; Alexander N Freiberg
Journal:  J Gen Virol       Date:  2015-03-10       Impact factor: 3.891

5.  Using click chemistry to measure the effect of viral infection on host-cell RNA synthesis.

Authors:  Birte Kalveram; Olga Lihoradova; Sabarish V Indran; Jennifer A Head; Tetsuro Ikegami
Journal:  J Vis Exp       Date:  2013-08-09       Impact factor: 1.355

6.  Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs.

Authors:  Olga Lihoradova; Tetsuro Ikegami
Journal:  Future Virol       Date:  2014-01-01       Impact factor: 1.831

7.  Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.

Authors:  Sabarish V Indran; Olga A Lihoradova; Inaia Phoenix; Nandadeva Lokugamage; Birte Kalveram; Jennifer A Head; Bersabeh Tigabu; Jennifer K Smith; Lihong Zhang; Terry L Juelich; Bin Gong; Alexander N Freiberg; Tetsuro Ikegami
Journal:  J Gen Virol       Date:  2013-03-20       Impact factor: 3.891

8.  Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.

Authors:  Olga A Lihoradova; Sabarish V Indran; Birte Kalveram; Nandadeva Lokugamage; Jennifer A Head; Bin Gong; Bersabeh Tigabu; Terry L Juelich; Alexander N Freiberg; Tetsuro Ikegami
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18

9.  The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.

Authors:  Benjamin Brennan; Stephen R Welch; Richard M Elliott
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

10.  Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase.

Authors:  Rajini Mudhasani; Julie P Tran; Cary Retterer; Krishna P Kota; Chris A Whitehouse; Sina Bavari
Journal:  PLoS Pathog       Date:  2016-02-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.